Skip to main content
. 2015 Oct 30;31:196–209. doi: 10.1007/s12928-015-0366-9

Table 4.

Clinical outcomes at 12 months

No. of patients with at least one event (cumulative incidence) P value
STOPDAPT (N = 1525) RESET (N = 1559)
Primary Endpoint 42 (2.8 %) 61 (4.0 %) 0.06
Death
 All-cause 30 (2.0 %) 25 (1.6 %) 0.49
 Cardiac death 9 (0.6 %) 13 (0.9 %) 0.4
 Cardiovascular death 10 (0.7 %) 15 (1.0 %) 0.33
 Non-cardiac death 21 (1.4 %) 12 (0.8 %) 0.11
Myocardial infarction 4 (0.3 %) 18 (1.2 %) 0.003
Stroke
 Any 17 (1.1 %) 21 (1.4 %) 0.51
 Ischemic 14 (0.9 %) 15 (1.0 %) 0.86
 Hemorrhagic 4 (0.3 %) 8 (0.5 %) 0.24
Bleeding
 TIMI major 12 (0.8 %) 12 (0.8 %) 0.99
 TIMI minor/major 15 (1.0 %) 20 (1.3 %) 0.4
 TIMI minimal/minor/major 37 (2.5 %) 38 (2.5 %) 0.9
 GUSTO severe 10 (0.7 %) 16 (1.0 %) 0.23
 GUSTO moderate/severe 16 (1.1 %) 19 (1.2 %) 0.61
Definite stent thrombosis
 All patients 0 (0 %) 4 (0.3 %) 0.046
 Acute (0–1 day) 0 (0 %) 0 (0 %)
 Subacute (2–30 days) 0 (0 %) 1 (0.06 %)
 Late (31–365 days) 0 (0 %) 3 (0.2 %)
Stent thrombosis
 Possible 6 (0.4 %) 7 (0.5 %) 0.78
 Probable 0 (0 %) 1 (0.07 %) 0.32
 Definite/probable 0 (0 %) 5 (0.3 %) 0.03
 Definite/probable/possible 6 (0.4 %) 12 (0.8 %) 0.16
Death or myocardial infarction 34 (2.2 %) 40 (2.6 %) 0.49
Cardiovascular death or myocardial infarction 14 (0.9 %) 30 (2.0 %) 0.02
Cardiovascular death, MI or stroke 31 (2.1 %) 49 (3.2 %) 0.045
Cardiovascular death, MI, stroke and definite ST 31 (2.1 %) 49 (3.2 %) 0.045
Target-lesion revascularization 30 (2.0 %) 62 (4.2 %) 0.0007
Target-vessel revascularization 55 (3.7 %) 102 (6.9 %) <0.0001
Coronary revascularization
 Any 109 (7.3 %) 175 (11.8 %) <0.0001
 Coronary artery bypass grafting 3 (0.2 %) 7 (0.5 %) 0.2

Values are expressed as number (%)

TIMI thrombolysis in myocardial infarction, GUSTO global utilization of streptokinase and tissue plasminogen activator for Occluded coronary arteries, MI myocardial infarction, ST stent thrombosis